VOYA Investment Management’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81M Buy
117,132
+72,967
+165% +$2.65M ﹤0.01% 881
2026
Q1
$1.35M Sell
44,165
-910
-2% -$30.1K ﹤0.01% 1356
2025
Q4
$1.62M Buy
45,075
+22,924
+103% +$700K ﹤0.01% 1302
2025
Q3
$534K Sell
22,151
-11,233
-34% -$235K ﹤0.01% 1732
2025
Q2
$492K Buy
+33,384
New +$389K ﹤0.01% 1904

Other funds holding INDV

VOYA Investment Management's INDV Position: Q2 2026 in Review

VOYA Investment Management increased its Indivior Pharmaceuticals (INDV) stake by 165% in Q2 2026, buying an estimated $2.65M and bringing the position to 117,132 shares worth $4.81M. The position accounts for ﹤0.01% of the portfolio, ranked #881.

VOYA Investment Management first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • VOYA Investment Management held 117,132 shares of Indivior Pharmaceuticals worth $4.81M as of Q2 2026.
  • VOYA Investment Management bought 72,967 Indivior Pharmaceuticals shares in Q2 2026, an estimated $2.65M.
  • Indivior Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #881 holding.
  • VOYA Investment Management first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.